Improving the American Drug Supply Chain Act of 2020

Bill Number

HR 8588

Introduced

Oct 13, 2020

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to b ...

Sponsor

Cosponsors

Topics

Congressional oversight Drug safety, medical device, and laboratory regulation Economic performance and conditions Emergency medical services and trauma care Emergency planning and evacuation Government studies and investigations Health Health care costs and insurance Health technology, devices, supplies Intellectual property Labor market Manufacturing Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

Improving the American Drug Supply Chain Act of 2020

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.

Actions

Oct 13, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 13, 2020

Introduced in House

Amendments

Related Bills